Washington. The metabolic alterations present in various cancers are increasingly studied as a possible therapeutic target. In particular, it is known that some types of tumors known as glutamine addicted, require large amounts of the amino acid glutamine in order to grow. This emerges from a study published in the prestigious journal of the American Society of Hematology ‘Blood’, the result of a coordinated research study in Parma by prof. Nicola Giuliani of the Department of Clinical and Experimental Medicine, University of Parma in collaboration with the research group of prof. Ovidio Bussolati General Pathology Unit of the Department of Biomedical, Biotechnology and Translational Sciences. (9Colonne)
